News
Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...
15don MSN
At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average dividend payer in the S&P 500. If it can't maintain its payout-raising streak, ...
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly ...
Regeneron, playing catch up with J&J and Pfizer, wins FDA approval for Lynozyfic in multiple myeloma
Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...
FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...
A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines ...
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines ...
The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...
The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results